These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 19277408

  • 21. Venous thromboembolism in very elderly patients: findings from a prospective registry (RIETE).
    López-Jiménez L, Montero M, González-Fajardo JA, Arcelus JI, Suárez C, Lobo JL, Monreal M, RIETE Investigators.
    Haematologica; 2006 Aug; 91(8):1046-51. PubMed ID: 16885044
    [Abstract] [Full Text] [Related]

  • 22. [Oral contraceptive pill and thrombotic risk: epidemiological studies].
    Fruzzetti F, Perini D, Spirito N, Manca R.
    Minerva Ginecol; 2012 Dec; 64(6):539-49. PubMed ID: 23232538
    [Abstract] [Full Text] [Related]

  • 23. Venous thromboembolism in women.
    Rathbun S.
    Vasc Med; 2008 Aug; 13(3):255-66. PubMed ID: 18687764
    [Abstract] [Full Text] [Related]

  • 24. [Hormonal contraception and risk of venous thromboembolism: When to ask for an assessment of hemostasis? Which parameters?].
    Plu-Bureau G, Horellou MH, Gompel A, Conard J.
    Gynecol Obstet Fertil; 2008 Apr; 36(4):448-54. PubMed ID: 18424163
    [Abstract] [Full Text] [Related]

  • 25. [Pregnancy, contraception and HRT and venous thromboembolism].
    Conard J, Gompel A.
    Rev Prat; 2007 Apr 15; 57(7):759-66. PubMed ID: 17626321
    [Abstract] [Full Text] [Related]

  • 26. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
    Jick SS, Kaye JA, Russmann S, Jick H.
    Contraception; 2006 Jun 15; 73(6):566-70. PubMed ID: 16730485
    [Abstract] [Full Text] [Related]

  • 27. The MASTER registry on venous thromboembolism: description of the study cohort.
    Agnelli G, Verso M, Ageno W, Imberti D, Moia M, Palareti G, Rossi R, Pistelli R, MASTER investigators.
    Thromb Res; 2008 Jun 15; 121(5):605-10. PubMed ID: 17692901
    [Abstract] [Full Text] [Related]

  • 28. [Peroral hormonal contraception and risk of venous thromboembolism].
    Ludka O, Spinar J, Musil V, Pozdísek Z.
    Vnitr Lek; 2010 May 15; 56(5):370-5. PubMed ID: 20578585
    [Abstract] [Full Text] [Related]

  • 29. Clinical outcome of patients with major bleeding after venous thromboembolism. Findings from the RIETE Registry.
    Nieto JA, Camara T, Gonzalez-Higueras E, Ruiz-Gimenez N, Guijarro R, Marchena PJ, Monreal M, RIETE Investigators.
    Thromb Haemost; 2008 Nov 15; 100(5):789-96. PubMed ID: 18989522
    [Abstract] [Full Text] [Related]

  • 30. Predicting recurrences or major bleeding in women with cancer and venous thromboembolism. Findings from the RIETE Registry.
    Trujillo-Santos J, Ruiz-Gamietea A, Luque JM, Samperiz AL, Garcia-Bragado F, Todoli JA, Monreal M, RIETE Investigators.
    Thromb Res; 2009 Nov 15; 123 Suppl 2():S10-5. PubMed ID: 19217463
    [Abstract] [Full Text] [Related]

  • 31. Venous thromboembolism associated with pregnancy and hormonal therapy.
    Jacobsen AF, Sandset PM.
    Best Pract Res Clin Haematol; 2012 Sep 15; 25(3):319-32. PubMed ID: 22959548
    [Abstract] [Full Text] [Related]

  • 32. Venous thromboembolism in patients with advanced cancer under palliative care: additional risk factors, primary/secondary prophylaxis and complications observed under normal clinical practice.
    Soto-Cárdenas MJ, Pelayo-García G, Rodríguez-Camacho A, Segura-Fernández E, Mogollo-Galván A, Giron-Gonzalez JA.
    Palliat Med; 2008 Dec 15; 22(8):965-8. PubMed ID: 18952751
    [Abstract] [Full Text] [Related]

  • 33. Seasonal variation in the occurrence of venous thromboembolism: data from the MASTER Registry.
    Manfredini R, Imberti D, Gallerani M, Verso M, Pistelli R, Ageno W, Agnelli G.
    Clin Appl Thromb Hemost; 2009 Dec 15; 15(3):309-15. PubMed ID: 18544594
    [Abstract] [Full Text] [Related]

  • 34. Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of contraceptive methods during the postpartum period.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2011 Jul 08; 60(26):878-83. PubMed ID: 21734635
    [Abstract] [Full Text] [Related]

  • 35. Hormonal contraception and venous thromboembolism.
    Lidegaard Ø, Milsom I, Geirsson RT, Skjeldestad FE.
    Acta Obstet Gynecol Scand; 2012 Jul 08; 91(7):769-78. PubMed ID: 22568831
    [Abstract] [Full Text] [Related]

  • 36. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review.
    Gomes MP, Deitcher SR.
    Arch Intern Med; 2004 Oct 11; 164(18):1965-76. PubMed ID: 15477430
    [Abstract] [Full Text] [Related]

  • 37. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
    Couturaud F, Duchemin J, Leroyer C, Delahousse B, Abgrall JF, Mottier D, Groupe d'Etude de la Thrombose de Bretagne Occidentale (G.E.T.B.O).
    Thromb Haemost; 2008 Jan 11; 99(1):223-8. PubMed ID: 18217158
    [Abstract] [Full Text] [Related]

  • 38. The relationship between lifestyle factors and venous thromboembolism among women: a report from the MISS study.
    Lindqvist PG, Epstein E, Olsson H.
    Br J Haematol; 2009 Jan 11; 144(2):234-40. PubMed ID: 19036105
    [Abstract] [Full Text] [Related]

  • 39. Hormones and pregnancy: thromboembolic risks for women.
    Kujovich JL.
    Br J Haematol; 2004 Aug 11; 126(4):443-54. PubMed ID: 15287937
    [Abstract] [Full Text] [Related]

  • 40. Risk factors for venous thromboembolism in women under combined oral contraceptive. The PILl Genetic RIsk Monitoring (PILGRIM) Study.
    Suchon P, Al Frouh F, Henneuse A, Ibrahim M, Brunet D, Barthet MC, Aillaud MF, Venton G, Alessi MC, Trégouët DA, Morange PE.
    Thromb Haemost; 2016 Jan 11; 115(1):135-42. PubMed ID: 26290123
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.